scholarly journals Meshalkin National Medical Research Center

2021 ◽  
Vol 26 (8) ◽  
pp. 4565
Author(s):  
A. V. Bogachev-Prokofiev ◽  
R. M. Sharifulin ◽  
D. A. Astapov ◽  
M. A. Ovcharov ◽  
M. A. Ovchinnikova ◽  
...  

We present three cases of successful transatrial transcatheter valve-in-valve implantation in patients with bioprosthetic mitral valve dysfunction. Patients with a high surgical risk, with severe heart failure due to bioprosthetic mitral valve dysfunction, were implanted with transcatheter prostheses using the transatrial approach.Transesophageal echocardiography and fluoroscopy-guided transcatheter mitral prosthetic valve positioning was performed. With a cardiac pacing at 180 bpm, a transcatheter valve was implanted. The transcatheter valves functioned properly after surgery. The patients were discharged in satisfactory condition.

2018 ◽  
Vol 93 (6) ◽  
pp. 1087-1094 ◽  
Author(s):  
Timothy A. Joseph ◽  
Mackram F. Eleid ◽  
Allison K. Cabalka ◽  
Joseph F. Maalouf ◽  
Charanjit S. Rihal

2016 ◽  
Vol 22 (4) ◽  
pp. 501-503 ◽  
Author(s):  
Isabel Baldizon ◽  
Andres Espinoza ◽  
Thomas Kuntze ◽  
Evaldas Girdauskas

2013 ◽  
Vol 61 (17) ◽  
pp. 1759-1766 ◽  
Author(s):  
Anson Cheung ◽  
John G. Webb ◽  
Marco Barbanti ◽  
Melanie Freeman ◽  
Ronald K. Binder ◽  
...  

2019 ◽  
Vol 87 (5) ◽  
pp. 380-382
Author(s):  
Juan R. Alderete ◽  
Alberto C. Anaya Revolledo ◽  
Verónica I. Volberg ◽  
Miguel Rubio ◽  
Gustavo E. Barrera ◽  
...  

2015 ◽  
Vol 19 (2) ◽  
pp. 36 ◽  
Author(s):  
L. S. Barbarash ◽  
A. N. Stasev ◽  
S. G. Kokorin ◽  
N. V. Rutkovskaya ◽  
I. N. Sizova

<p><strong>Background</strong>. Patients with bioprosthetic valve dysfunction have a higher risk for redo procedures because of advanced age, comorbidities and redo-related technical difficulties. Thus, valve-in-valve replacement seems to be an easier and safer option for this group of patients.<br />Objective. To assess the immediate results of mitral valve-in-valve implantation for bioprosthetic valve dysfunction.<br /><strong>Methods</strong>. 6 patients underwent mitral valve-in-valve implantation using “UniLine” prostheses at Kemerovo Research Institute for Complex Problems of Cardiovascular Diseases in 2014.<br /><strong>Results.</strong> There were no cases of in-hospital deaths and prosthesis-related complications in the group under study. Satisfactory performance of bioprostheses was confirmed by echocardiography offered to all the patients before their discharge. <br /><strong>Conclusion.</strong> Mitral valve-in-valve implantation for bioprosthetic valve dysfunction allows achieving satisfactory immediate results.</p>


2021 ◽  
Vol 14 (11) ◽  
pp. e244270
Author(s):  
Mark Zachary Johnson ◽  
Nicholas James Damianopoulos ◽  
Felicity Lee ◽  
Gerald Yong

A 32-year-old, 11-week pregnant African woman with known rheumatic heart disease presented to the emergency department with worsening shortness of breath on exertion. She had undergone a double bioprosthetic valve replacement and left atrial appendage resection 8 years prior for severe mitral stenosis, moderate mitral regurgitation and moderate aortic regurgitation. A transo-oesophageal echocardiography at this presentation confirmed a morphologically calcified and stenosed mitral bioprosthesis, with moderate stenosis of her aortic bioprosthesis. Her multidisciplinary team, including cardiologists, cardiothoracic surgeons and obstetricians, came to a consensus decision to proceed with a transseptal transcatheter valve implantation within the mitral valve prosthesis (valve-in-valve implantation). Transthoracic echocardiography performed 2 months post procedure showed satisfactory mitral valve gradients and at 30 weeks’ gestation, she successfully delivered her fifth child. 2 years later, the valve in valve complex is still functioning well.


2018 ◽  
Vol 121 (12) ◽  
pp. 1593-1600 ◽  
Author(s):  
Saroj Neupane ◽  
Hemindermeet Singh ◽  
Johannes Lämmer ◽  
Hussein Othman ◽  
Hiroshi Yamasaki ◽  
...  

2014 ◽  
Vol 12 (9) ◽  
pp. 1035-1036 ◽  
Author(s):  
Stamatios Lerakis ◽  
Salim S Hayek ◽  
Vinod Thourani ◽  
Vasilis Babaliaros

2021 ◽  
Vol 5 (7) ◽  
Author(s):  
Christian Butter ◽  
Ralf-Uwe Kühnel ◽  
Frank Hölschermann

Abstract Background Degenerated and failed bioprosthetic cardiac valves can safely be treated with transcatheter valve-in-valve implantation in patients at high risk for reoperation. So far, non-functional mechanical valves must be treated with a surgical redo. Breaking the carbon leaflets before implanting a transcatheter valve into the remaining ring has never been described before. Case summary Here, we present the case of a 65-year-old male patient with severe heart failure, poor left ventricular function based on a fully immobile disc of his mechanical bileaflet aortic valve implanted 7 years ago. After the heart team declined to reoperate the patient due to his extremely high risk, we considered a transcatheter valve-in-valve implantation as the ultimate treatment approach. After successful interventional cracking of the leaflets in vitro, this approach, together with implanting a balloon-expandable transcatheter aortic valve replacement (TAVR) into the remaining ring, was performed under cerebral protection. The intervention resulted in a fully functional TAVR, improvement of heart function, and early discharge from the hospital. Discussion This case demonstrates the possibility to implant a transcatheter valve successfully into a non-functional mechanical bileaflet aortic prosthesis after fracturing the carbon discs while the brain is protected by a filter system. Critical steps of the procedure were identified. This new therapeutic approach might be offered to a limited patient cohort who is not eligible for a surgical redo.


Sign in / Sign up

Export Citation Format

Share Document